How Lymphoma Medications Work

Lymphoma medications work by targeting and killing cancer cells in the lymphatic system. The most common treatment for lymphoma is chemotherapy, specifically the CHOP regimen (cyclophosphamide, doxorubicin, vincristine, and prednisone). This combination of drugs works by:

• Cyclophosphamide: Interfering with DNA replication in cancer cells
• Doxorubicin: Inhibiting topoisomerase II, an enzyme essential for cell division
• Vincristine: Binding to tubulin and disrupting microtubule formation
• Prednisone: Suppressing the immune system's response to cancer cells

Other treatment options include targeted therapy (e.g., brentuximab vedotin for CD30-positive lymphoma), immunotherapy (e.g., nivolumab or pembrolizumab for refractory disease), and hematopoietic stem cell transplantation for high-risk or relapsed disease. These treatments work by:

• Targeted therapy: Binding to specific proteins on cancer cells, such as CD30
• Immunotherapy: Enhancing the immune system's ability to recognize and attack cancer cells
• Hematopoietic stem cell transplantation: Replacing damaged bone marrow with healthy stem cells

The goal of lymphoma treatment is to induce remission, which means eliminating detectable cancer cells from the body. Treatment duration and intensity depend on various factors, including disease stage, patient age, and overall health.